Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16.
about
Tracking methicillin-resistant Staphylococcus aureus clones during a 5-year period (1998 to 2002) in a Spanish hospitalChanges in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospitalRapid detection of the pandemic methicillin-resistant Staphylococcus aureus clone ST 239, a dominant strain in Asian hospitals.Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: surveillance over a 16-year period.Evolutionary blueprint for host- and niche-adaptation in Staphylococcus aureus clonal complex CC30.Gemmacin B: bringing diversity back into focus.The discovery of antibacterial agents using diversity-oriented synthesis.Comparative genomics of Staphylococcus aureus musculoskeletal isolates.Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in MalaysiaSeven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland.Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predominance of SCCmec types IV, V and VI.The agr radiation: an early event in the evolution of staphylococciMolecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998.Induction of the staphylococcal proteolytic cascade by antimicrobial fatty acids in community acquired methicillin resistant Staphylococcus aureusStaphylococcus aureus strains that are hypersusceptible to resistance gene transfer from enterococci.Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.A microfluidic platform for rapid, stress-induced antibiotic susceptibility testing of Staphylococcus aureus.Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus.Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.Update on the major clonal types of methicillin-resistant Staphylococcus aureus in the Czech Republic.Molecular epidemiology of clinically significant antibiotic resistance genes.Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods.Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia.Origins and evolution of methicillin-resistant Staphylococcus aureus clonal lineages.Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics.International clones of methicillin-resistant Staphylococcus aureus in two hospitals in Miami, FloridaThe dissemination of ST80-SCCmec-IV community-associated methicillin resistant Staphylococcus aureus clone in Kuwait hospitals.Prevalence and evolution of methicillin-resistant Staphylococcus aureus in Spanish hospitals between 1996 and 2002.Isolation and characterization of an epidemic methicillin-resistant Staphylococcus aureus 15 variant in the central United States.First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany.Emergence of MRSA clone ST22 in healthy young adults in the community in the absence of risk factors.Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time.Anti-MRSA agent discovery using diversity-oriented synthesis.Investigation of a Cluster of Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Transmission in a Community Setting.
P2860
Q30343790-7B4B8218-7503-4E73-8B98-C978E1DB4404Q30362877-18414E58-ECC4-4312-A495-338F65BE9E27Q30367475-608E99D4-ACBD-43F7-8FF4-074BB67C9414Q30370523-C5FBEDE8-783C-4476-8A2D-A95549BE3EC9Q30420650-C894374A-7161-46A2-820E-0AA7E082618AQ33358708-1FCFE5C9-92D6-43D2-8632-242A2EA5978AQ33469588-8F01A452-2766-4ED7-8350-E4FA98731E3FQ33699183-EEF485C3-F5C4-4E4F-8F9A-28B820C9E7EFQ33702000-5826CF73-BEF8-4177-BD64-2F1E8FA7E570Q33704706-2BF939AB-CA07-48B9-B42E-ECD5306569A9Q33770114-0A1D6079-F803-43D2-8938-FB1E80ACB8C6Q33788342-4C81463A-851B-437B-8BC3-AED7A9E6959EQ33937521-5150E4AE-1A9F-4404-9905-7D259A72AFDEQ34143675-9CDA2903-2BD6-4437-8155-21DD2AC5D6BEQ34430475-D00491A9-33D8-4A2F-8C8F-14A21278AEA3Q35840823-DA34DC43-CC5A-4CC2-8ED9-DAA7369D5D50Q35873229-298E4B27-8C9E-49C4-8C15-3044448FA5E9Q36371874-26980E89-C2D6-45B0-80C0-DDE6EC3B2E0DQ36384564-97331194-8848-4284-BDDF-9DA8B93777F1Q36409465-36B67DD2-A7A3-4255-AA68-543E72D532E5Q36508062-A33DA180-B496-47CF-B149-D21D08023BD8Q37059060-BB458568-B234-47E1-AA74-F69CF9218561Q37098582-86D6B348-D577-49A3-9B71-9A73A187B20BQ37214008-F4107FBB-C034-4656-8A56-E7F4816B9972Q37576588-F6F5138A-2FD9-470A-B66A-5CF9BBACD0DAQ38665220-3011FB65-4FF1-40E9-8292-7DAA089F4632Q39799306-60D283A3-9FD2-4BF8-829B-4237867225EAQ40585407-FFD9D410-0284-4B4F-8DA5-842FD4D0D0F5Q41671725-000EBD7C-720E-4A45-9F32-1DE426801DC5Q42018138-F38EC122-0A53-4377-A802-35AE60E93C1DQ43193847-C5235088-3F85-4D3A-9AC1-E8BACF7D1F42Q43223444-80A50AAB-927C-4184-8BD7-BACEF29F9185Q44301180-E5599196-937D-423F-ABFE-BF6CD7648348Q44593794-144DEEB8-8B14-4520-A1B4-E6D7FEB07AD3Q46728360-2DF5A04E-00F6-4F85-AF9A-C8C3CCF97919Q50097033-C64AE194-6333-462E-B3FF-E9639C92C91C
P2860
Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Molecular characterisation of ...... trains, EMRSA-15 and EMRSA-16.
@en
Molecular characterisation of ...... trains, EMRSA-15 and EMRSA-16.
@nl
type
label
Molecular characterisation of ...... trains, EMRSA-15 and EMRSA-16.
@en
Molecular characterisation of ...... trains, EMRSA-15 and EMRSA-16.
@nl
prefLabel
Molecular characterisation of ...... trains, EMRSA-15 and EMRSA-16.
@en
Molecular characterisation of ...... trains, EMRSA-15 and EMRSA-16.
@nl
P1476
Molecular characterisation of ...... trains, EMRSA-15 and EMRSA-16.
@en
P2093
J A Lindsay
P C L Moore
P304
P356
10.1099/0022-1317-51-6-516
P577
2002-06-01T00:00:00Z